Our group employed adoptive transfer of CD4+ iNKT cells to major histocompatibility complex (MHC)-mismatched murine models of GVHD to demonstrate protective effects of donor-type (3, 195) as well as third-party (150) iNKT cells against GVHD. Here, CD4 is linked to graft versus host disease.